Identification of gene markers associated with prognosis for patients with prostate cancer

Not Applicable

Completed

• Conditions: Prognostic markers of prostate cancer; Cancer

• Registration Number: ISRCTN11560295
• Lead Sponsor: Sichuan University

Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36217461/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35280985/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36109820/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35463369/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36144737/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35658892/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35096608/ (added 06/01/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-12-01
• Study Completion: 2021-12-10
• Last Update Posted: 16 January 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 3000

Inclusion Criteria

Patients with prostate cancer in the TCGA and GEO databases

Exclusion Criteria

Patients without prognostic information in the TCGA and GEO databases

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Genes associated with biochemical recurrence, identified through bioinformatic analysis of data obtained from the TCGA and GEO database from 01/12/2021 to 05/12/2021

Secondary Outcome Measures

Name	Time	Method
There are no secondary outcome measures